Nab Taxhal Injection belongs to the group of anti-cancer medicines used to treat various types of cancers, including breast cancer, pancreatic cancer, and non-small cell lung cancer. Breast cancer, pancreatic cancer, and non-small cell lung cancer are types of cancer that develop in the breast tissue, pancreas, and lungs, respectively, causing abnormal cell growth and tumor formation.

Nab Taxhal Injection contains Paclitaxel and Human Albumin, which work together to combat cancer. Paclitaxel stops cell division and prevents the growth of certain cancer cells by stabilizing microtubules, while human albumin acts as a carrier protein, delivering paclitaxel to cancer cells and enhancing its effectiveness.

In some cases, Nab Taxhal Injection may cause common side effects, such as numbness or tingling in hands and feet, tiredness, nausea and vomiting, diarrhea, hair loss, joint and muscle pain, swelling in hands or feet, and fever. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen.

Please inform your doctor before taking Nab Taxhal Injection if you are allergic to it or any of its components. It is essential to inform your doctor about any existing heart disease, liver or kidney problems, or medications you're taking to treat infections to ensure safe and effective treatment. Consult your doctor if you are pregnant, breastfeeding, think you may be pregnant, or are planning pregnancy. Nab Taxhal Injection is not recommended for children under 18 years. Inform your doctor about your health condition and medications to rule out any side effects.

Nab Taxhal Injection is used in the treatment of cancer, including breast cancer, pancreatic cancer, and non-small cell lung cancer. The detailed uses of Nab Taxhal Injection are as follows:

• Treatment of Breast Cancer: Nab Taxhal Injection treats breast cancer by targeting and killing cancer cells and inhibiting tumor growth.
• Treatment of Pancreatic Cancer: Nab Taxhal Injection effectively treats pancreatic cancer by targeting cancer cells, often used in combination with gemcitabine (Gemzar) to enhance therapeutic outcomes.
• Treatment of Non-Small Cell Lung Cancer (NSCLC): Nab Taxhal Injection treats non-small cell lung cancer by binding to microtubules, disrupting cell division, and inducing apoptosis (cell death.

• Follow your doctor's instructions on the dosage and timing of this medication to ensure safe and effective use.
• Nab Taxhal Injection should be administered by a nurse or doctor to ensure proper dosage, technique, and monitoring for any potential side effects or complications.
• Do not self-administer.

Nab Taxhal Injection provides several medicinal benefits when used together. Paclitaxel exhibits anti-cancer properties, inhibiting cell division, stabilizing microtubules, and inducing apoptosis in cancer cells. Human albumin enhances paclitaxel's delivery to cancer cells, improving its solubility and bioavailability. Additionally, human albumin acts as a plasma volume expander and binding agent, transporting essential substances. Together, they enhance cancer treatment efficacy, improve outcomes, reduce side effects, and increase patient survival rates.

Do not take Nab Taxhal Injection if you are allergic to Nab Taxhal Injection or any of its components. Before receiving Nab Taxhal Injection, inform your doctor if you have low blood cell counts, uncontrolled infections, Kaposi's sarcoma, or severe liver issues. Inform your doctor if you have heart disease, abnormal blood cell counts, irregular heartbeat, tingling, numbness, or a burning sensation in fingers or toes; if you are on radiation therapy; or if you have Kaposi’s sarcoma and have a sore or inflamed mouth. Nab Taxhal Injection may cause fatigue. Be cautious when driving, operating machinery, or performing activities requiring alertness. Nab Taxhal Injection is not recommended for children below 18 years. Also, inform your doctor if you are pregnant, breastfeeding, think you are pregnant, or are planning pregnancy.